Melanoma Skin Cancer clinical trials

Explore recruiting melanoma skin cancer clinical trials.

Recruiting melanoma skin cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Melanoma Skin Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase II study of intratumoral administration of L19IL2/L19TNF in non-melanoma skin cancer patients with presence of injectable lesions.

Poland, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial to investigate the efficacy and safety of daxdilimab subcutaneous injection in reducing disease activity in adult participants with moderate-to-severe primary discoid lupus erythematosus.

Denmark, France, Czechia, Germany, Poland, Greece +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Electrochemotherapy versus standard radiotherapy for the treatment of basal cell carcinoma

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Efficacyand Safety Study Of Daxdilimab Subcutaneous Injection In Adult Participants With Inadequately Controlled Dermatomyositis Or Anti-Synthetase Inflammatory Myositis

Spain, Italy, Germany, Czechia, France

Therapeutic exploratory (Phase II) EU CTIS Study details

Melanoma Skin Cancer trials by city

Melanoma Skin Cancer in Toronto Melanoma Skin Cancer in Vancouver Melanoma Skin Cancer in Montreal Melanoma Skin Cancer in Calgary Melanoma Skin Cancer in Edmonton Melanoma Skin Cancer in Ottawa Melanoma Skin Cancer in Winnipeg Melanoma Skin Cancer in Quebec City Melanoma Skin Cancer in Hamilton Melanoma Skin Cancer in Kitchener Melanoma Skin Cancer in London Melanoma Skin Cancer in Halifax Melanoma Skin Cancer in New York Melanoma Skin Cancer in Los Angeles Melanoma Skin Cancer in Chicago Melanoma Skin Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease